Louise Wang Zhiying Humphrey

Array ( [id] => 6182752 [patent_doc_number] => 20110179508 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-21 [patent_title] => 'ENTEROVIRUS TYPE 71 PROTEIN AND METHOD FOR PRODUCTION' [patent_app_type] => utility [patent_app_number] => 13/034355 [patent_app_country] => US [patent_app_date] => 2011-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 5867 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0179/20110179508.pdf [firstpage_image] =>[orig_patent_app_number] => 13034355 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7696719 [patent_doc_number] => 20110229871 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-22 [patent_title] => 'NUCLEOSIDE-CONTAINING COMPOSITIONS AND METHODS FOR TREATING RED BLOOD CELLS' [patent_app_type] => utility [patent_app_number] => 13/028819 [patent_app_country] => US [patent_app_date] => 2011-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5722 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0229/20110229871.pdf [firstpage_image] =>[orig_patent_app_number] => 13028819 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6110025 [patent_doc_number] => 20110189105 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-04 [patent_title] => 'GRIFFITHSIN, GLYCOSYLATION-RESISTANT GRIFFITHSIN, AND RELATED CONJUGATES, COMPOSITIONS, NUCLEIC ACIDS, VECTORS, HOST CELLS, METHODS OF PRODUCTION AND METHODS OF USE' [patent_app_type] => utility [patent_app_number] => 13/022289 [patent_app_country] => US [patent_app_date] => 2011-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 26464 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0189/20110189105.pdf [firstpage_image] =>[orig_patent_app_number] => 13022289 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6054587 [patent_doc_number] => 20110110947 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-12 [patent_title] => 'VIRAL CHEMOKINE-ANTIGEN FUSION PROTEINS' [patent_app_type] => utility [patent_app_number] => 13/009572 [patent_app_country] => US [patent_app_date] => 2011-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33792 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0110/20110110947.pdf [firstpage_image] =>[orig_patent_app_number] => 13009572 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9344803 [patent_doc_number] => 08663950 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-03-04 [patent_title] => 'Production of a monoclonal antibody therapeutic against west nile virus in plants' [patent_app_type] => utility [patent_app_number] => 13/521431 [patent_app_country] => US [patent_app_date] => 2011-01-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 8758 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 128 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13521431 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10091276 [patent_doc_number] => 09128094 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-09-08 [patent_title] => 'High throughput cell-based HPV immunoassays for diagnosis and screening of HPV-associated cancers' [patent_app_type] => utility [patent_app_number] => 13/520021 [patent_app_country] => US [patent_app_date] => 2010-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 41 [patent_no_of_words] => 32245 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 207 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13520021 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8522260 [patent_doc_number] => 20120321668 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-12-20 [patent_title] => 'PEPTIDES DERIVED FROM HIV-1 gp41 TRANSMEMBRANE' [patent_app_type] => utility [patent_app_number] => 13/512556 [patent_app_country] => US [patent_app_date] => 2010-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 19678 [patent_no_of_claims] => 52 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13512556 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8554713 [patent_doc_number] => 08329182 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-12-11 [patent_title] => 'Immunoglobulin chimeric monomer-dimer hybrids' [patent_app_type] => utility [patent_app_number] => 12/952551 [patent_app_country] => US [patent_app_date] => 2010-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 40 [patent_no_of_words] => 36971 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12952551 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9958213 [patent_doc_number] => 09006420 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-04-14 [patent_title] => 'Method for concentrating and isolating biomolecules or viruses' [patent_app_type] => utility [patent_app_number] => 12/941783 [patent_app_country] => US [patent_app_date] => 2010-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4551 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12941783 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9355552 [patent_doc_number] => 08674085 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-03-18 [patent_title] => '2′-branched nucleosides and Flaviviridae mutation' [patent_app_type] => utility [patent_app_number] => 12/914914 [patent_app_country] => US [patent_app_date] => 2010-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 44978 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12914914 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8648852 [patent_doc_number] => 20130034582 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-02-07 [patent_title] => 'REVERSE GENETICS METHODS FOR VIRUS RESCUE' [patent_app_type] => utility [patent_app_number] => 13/503353 [patent_app_country] => US [patent_app_date] => 2010-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 13765 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13503353 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8405485 [patent_doc_number] => 20120237544 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-09-20 [patent_title] => 'BACTERIAL SPORE HAVING THERAPEUTIC AGENT ADSORBED ON ITS SURFACE' [patent_app_type] => utility [patent_app_number] => 13/497169 [patent_app_country] => US [patent_app_date] => 2010-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 15168 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13497169 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9250312 [patent_doc_number] => 08614090 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-12-24 [patent_title] => 'Astrovirus species' [patent_app_type] => utility [patent_app_number] => 12/859068 [patent_app_country] => US [patent_app_date] => 2010-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 29373 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12859068 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9951352 [patent_doc_number] => 09000139 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-04-07 [patent_title] => 'Composition for preventing or treating cervical cancer having human papillomavirus plasmodium and immunity enhancer' [patent_app_type] => utility [patent_app_number] => 13/816716 [patent_app_country] => US [patent_app_date] => 2010-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 5320 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13816716 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9589112 [patent_doc_number] => 08778653 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-07-15 [patent_title] => 'Method for reducing DNA impurities in viral compositions' [patent_app_type] => utility [patent_app_number] => 13/813897 [patent_app_country] => US [patent_app_date] => 2010-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9643 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13813897 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7696684 [patent_doc_number] => 20110229906 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-22 [patent_title] => 'Means and methods for monitoring protease inhibitor antiretroviral therapy and guiding therapeutic decisions in the treatment of HIV/AIDS' [patent_app_type] => utility [patent_app_number] => 12/841171 [patent_app_country] => US [patent_app_date] => 2010-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 52 [patent_figures_cnt] => 52 [patent_no_of_words] => 44411 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0229/20110229906.pdf [firstpage_image] =>[orig_patent_app_number] => 12841171 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5992569 [patent_doc_number] => 20110014222 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-20 [patent_title] => 'Stereoisomer Peptides and Their Polymer Conjugates for HIV Disease' [patent_app_type] => utility [patent_app_number] => 12/836187 [patent_app_country] => US [patent_app_date] => 2010-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 17577 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20110014222.pdf [firstpage_image] =>[orig_patent_app_number] => 12836187 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6054610 [patent_doc_number] => 20110110970 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-12 [patent_title] => 'CHIMERIC VACCINES' [patent_app_type] => utility [patent_app_number] => 12/824835 [patent_app_country] => US [patent_app_date] => 2010-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 29288 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0110/20110110970.pdf [firstpage_image] =>[orig_patent_app_number] => 12824835 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7702644 [patent_doc_number] => 08088397 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-01-03 [patent_title] => 'Human lymphocyte vaccine adjuvant' [patent_app_type] => utility [patent_app_number] => 12/824577 [patent_app_country] => US [patent_app_date] => 2010-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 37 [patent_no_of_words] => 6859 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/088/08088397.pdf [firstpage_image] =>[orig_patent_app_number] => 12824577 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6601557 [patent_doc_number] => 20100322943 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-23 [patent_title] => 'THERAPEUTIC AND DIAGNOSTIC AFFINITY PURIFIED SPECIFIC POLYCLONAL ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 12/816520 [patent_app_country] => US [patent_app_date] => 2010-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 14821 [patent_no_of_claims] => 62 [patent_no_of_ind_claims] => 36 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0322/20100322943.pdf [firstpage_image] =>[orig_patent_app_number] => 12816520 [rel_patent_id] =>[rel_patent_doc_number] =>)